Clinical Trial Update: A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA) [Phase 2]

View source ↗

Summary

This phase 2 trial evaluated the mechanism of action of ruxolitinib cream in subjects with vitiligo; the study has completed and results were posted in December…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Vitiligo | Phase 2 | Status: COMPLETED | Results posted: 2023-12-07